- Barnes G L, Kostenuik P J, Gerstenfeld L C, Einhorn T A. Growth factor regulation of fracture repair. J Bone Miner Res 1999; 14(11)1805–15
- Bhandari M, Shaughnessy S. A minimally invasive percutaneous technique of intramedullary nail insertion in an animal model of fracture healing. Arch Orthop Trauma Surg2001; 2001; 121(10)591–3
- Bjurholm A, Kreicbergs A, Schultzberg M, Lerner U H. Parathyroid hormone and noradrenaline-induced enhancement of cyclic AMP in a cloned osteogenic sarcoma cell line (UMR 106) is inhibited by neuropeptide Y. Acta Physiol Scand 1988; 134(3)451–2
- Bjurholm A, Kreicbergs A, Schultzberg M, Lerner U H. Neuroendocrine regulation of cyclic AMP formation in osteo blastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J Bone Miner Res 1992; 7(9)1011–9
- Bolander M E. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1992; 200(2)165–70
- Canalis E, McCarthy T L, Centrella M. The role of growth factors in skeletal remodeling. Endocrinol Metab Clin North Am 1989; 18(4)903–18
- Canalis E, McCarthy T L, Centrella M. Growth factors and cytokines in bone cell metabolism. Annu Rev Med 1991; 42: 17–24
- Croteau S, Rauch F, Silvestri A, Hamdy R C. Bone mor-phogenetic proteins in orthopedics: from basic science to clinical practice. Orthopedics 1999; 22(7)685–695, quiz 696-7
- Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000; 289(5484)1501–4
- Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267(16)10931–4
- Frost A, Jonsson K B, Brandstrom H, Ljunghall S, Nilsson O, Ljunggren O. Interleukin (IL)-13 and IL‐4 inhibit proliferation and stimulate IL‐6 formation in human osteo blasts: evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha. Bone 2001; 28(3)268–74
- Hiltunen A, Vuorio E, Aro H T. A standardized experimental fracture in the mouse tibia. J Orthop Res 1993; 11(2)305–12
- Kang S C, Matsutani T, Choudhry M A, Schwacha M G, Rue L W, Bland K I. Are the immune responses different in middle-aged and young mice following bone fracture, tissue trauma and hemorrhage?. Cytokine 2004; 26(5)223–30
- Kon T, Cho T J, Aizawa T, Yamazaki M, Nooh N, Graves D. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 2001; 16(6)1004–14
- Lewis D B, Liggitt H D, Effmann E L, Motley S T, Teitel-baum S L, Jepsen K J. Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci U S A 1993; 90(24)11618–22
- Linkhart T A, Mohan S, Baylink D J. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone (1 Suppl) 1996; 19: 1S–12S
- Mack V E, McCarter M D, Naama H A, Calvano E S, Daly J M. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996; 131(12)1303–1308, discussion 1308-9
- McKenzie G J, Fallon P G, Emson C L, Grencis R K, McKenzie A N. Simultaneous disruption of interleukin (IL)-4 and IL‐13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999; 189(10)1565–72
- Meert K L, Ofenstein P J, ,Sarnaik A P. Altered T cell cytokine production following mechanical trauma. Ann Clin Lab Sci 1998; 28(5)283–8
- Nilsson O S, Bauer H C, Brosjo O, Tornkvist H. Influence of indomethacin on induced heterotopic bone formation in rats. Importance of length of treatment and of age. Clin Orthop 1986, 207: 239–45
- Olmedo M L, Landry P S, Sadasivan K K, Albright J A, Meek W D, Routh R. Regulation of osteoblast levels during bone healing. J Orthop Trauma 1999; 13(5)356–62
- Reddi A H. Initiation of fracture repair by bone morphoge-netic proteins. Clin Orthop 1998, 355 Suppl: S66–72
- Schmidmaier G, Wildemann B, Heeger J, Gabelein T, Flyvbjerg A, Bail H J. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor‐1 and transforming growth factor-beta1. Bone 2002; 31(1)165–72
- Shore E M, Glaser D L, Gannon F H. Osteogenic induction in hereditary disorders of heterotopic ossification. Clin Orthop 2000, 374: 303–316
- Silfversward C J, Frost A, Brandstrom H, Nilsson O, Ljunggren O. Interleukin-4 and interleukin‐13 potentiate interleukin‐1 induced secretion of interleukin‐6 in human osteoblast-like cells. J Orthop Res 2004; 22(5)1058–62
- Silfversward C J, Larsson S, Ohlsson C, Frost A, Nilsson O. Reduced cortical bone mass in mice with inactivation of interleukin‐4 and interleukin-13. J Orthop Res 2007; 25(6)725–31
- Sisask G, Bjurholm A, Ahmed M, Kreicbergs A. The development of autonomic innervation in bone and joints of the rat. J Auton Nerve Syst 1996; 59(1-2)27–33
- Skoglund B, Forslund C, Aspenberg R. Simvastatin improves fracture healing in mice. J Bone Miner Res 2002; 17(11)2004–8
- Street J, Winter D, Wang J H, Wakai A, McGuinness A, Redmond H R. Is human fracture hematoma inherently angiogenic?. Clin Orthop 2000, 378: 224–237
- Szczesny G. Molecular aspects of bone healing and remodeling. Pol J Pathol 2002; 53(3)145–53
- Urist M R, DeLange R J, Finerman G A. Bone cell differentiation and growth factors. Science 1983; 220(4598)680–6
- Wildemann B, Schmidmaier G, Ordel S, Stange R, Haas N P, Raschke M. Cell proliferation and differentiation during fracture healing are influenced by locally applied IGF-I and TGF-beta1: comparison of two proliferation markers, PCNA and BrdU. J Biomed Mater Res B Appl Biomater 2003; 65(1)150–156
- Windahl S H, Vidal O, Andersson G, Gustafsson J A, Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 1999; 104(7)895–901
- Wozney J M, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998, 346: 26–37
- Zellweger R, Ayala A, DeMaso C M, Chaudry I H. Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 1995; 4(2)149–53
Acta Orthopaedica
Volume 79, 2008 - Issue 3